Early treatment for HIV slows damage to immune system and reduces risk of transmission
A 48-week course of antiretroviral medication taken in the early stages of HIV infection slows the damage to the immune system and delays the need fo1
A 48-week course of antiretroviral medication taken in the early stages of HIV infection slows the damage to the immune system and delays the need fo1
The CELLEX Biomedical Research Center has been presented, a new space where professionals from the Institut d’Investigacions Biomèdiques August Pi i1
The dawn of 30 December, Dr. Moises Broggi i Vallès died at 104 years in Barcelona. Dr. Broggi had a long career in which he was recognized with seve1
Combination antiretroviral therapy (cART) is a success of modern medicine that greatly improves survival and quality of life of HIV-1–infected patie1
2012 is ending, a difficult year also for science due to the crisis affecting much of the world. Despite this, it's not all are bad news. The spanis1
La Marató of TV3 (Catalan Telethon), this year dedicated to cancer, got on December 16 a new record of participation and collection. The 2,000 popul1
Plasma cell leukemia (PCL) is a rare and aggressive variant of myeloma characterized by the presence of circulating plasma cells. It is classified a1